Codes / ICD10CM / M72

M72 Fibroblastic disorders

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Fibroblastic disorders

Summary

Fibroblastic disorders are a group of conditions characterized by abnormal fibrous tissue growth, often involving the proliferation of fibroblasts and excessive collagen deposition. These disorders can affect various tissues and may lead to structural changes, pain, or functional impairment.

Causes

The exact causes of fibroblastic disorders are not fully understood, but they may involve dysregulated fibroblast activity, genetic factors, or abnormal wound healing responses. Some cases are associated with trauma, inflammation, or underlying systemic conditions.

Risk Factors

  • Age: More common in middle-aged or older adults.
  • Gender: Certain types may have gender predilections (e.g., higher prevalence in men for some fibromatoses).
  • Genetics: Family history of fibroblastic disorders or related conditions.
  • Chronic irritation or trauma: Repeated injury or inflammation to affected tissues.
  • Systemic diseases: Conditions like diabetes or epilepsy may increase risk.

Symptoms

  • Nodules or firm masses in soft tissues.
  • Pain or discomfort in affected areas.
  • Restricted movement or functional impairment.
  • Visible thickening or contracture of tissues (e.g., in hands or feet).
  • Gradual progression of symptoms over time.

Diagnosis

Diagnosis typically involves a physical examination to assess tissue changes, along with imaging (e.g., ultrasound, MRI) to evaluate fibrous tissue extent. Biopsy may be performed to confirm fibroblastic activity and rule out other conditions.

Treatment Options

  • Observation: For mild or asymptomatic cases, regular monitoring may suffice.
  • Conservative management: Physical therapy, stretching, or orthotic devices to improve function.
  • Medications: Anti-inflammatory drugs or targeted therapies to reduce fibrous growth.
  • Interventional procedures: Surgical removal or minimally invasive techniques for symptomatic lesions.

Prognosis and Follow-Up

Prognosis varies by specific disorder and severity. Some cases stabilize or progress slowly, while others may require ongoing management. Regular follow-up is important to monitor for changes or complications.

Complications

  • Tissue contracture leading to permanent deformity.
  • Functional limitations affecting daily activities.
  • Recurrence after treatment.
  • Potential nerve compression or vascular involvement in severe cases.

Lifestyle & Prevention

  • Avoid repetitive trauma or excessive stress to affected areas.
  • Maintain flexibility through regular exercise or stretching.
  • Manage underlying conditions (e.g., diabetes) to reduce risk.
  • Seek early evaluation for persistent symptoms to prevent progression.

When to Seek Professional Help

Consult a healthcare provider if you notice new or worsening nodules, pain, or restricted movement. Prompt evaluation is recommended for significant functional impairment or rapid symptom progression.

Tips for Medical Coders

When coding for fibroblastic disorders, ensure documentation specifies the anatomical location (e.g., palmar, plantar) and clinical details (e.g., nodules, contracture). Use the appropriate subcategory under M72 based on the specific disorder and its characteristics. Verify that supporting documentation aligns with the coded condition to support medical necessity.

Book a walkthrough

M72 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.